Oxagen
Innovative biopharmaceutical solutions advancing treatment options for asthma, autoimmune diseases, and more since 1997.
General Information
Get notified when Oxagen moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Discover More
About Oxagen
Taxonomy: biopharmaceutical, drug discovery, molecule drugs, asthma treatment, autoimmune disease treatment, inflammatory bowel disease treatment, psoriasis treatment, allergy treatment, rheumatoid arthritis treatment, Abingdon, United Kingdom, innovation, pharmaceutical industry
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series C | •••••• | 10 |
|
24 Nov 2009 |
| Series B | •••••• | - | 23 May 2005 | |
| Venture Round | •••••• | - | 21 Dec 2000 |
Oxagen Alternatives & Competitors
Providing high quality, diagnostic treatments & services for patients with diseases of the heart & v...
Arizona’s choice for vein and artery care since 2005. Providing unparalleled patient-centered diagno...
Transform healthcare and early disease detection through the power of multi-omics data.
FAQ About Oxagen
Don't just browse. Track.
Signal Tracker monitors Oxagen and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.